Found: 17
Select item for more details and to access through your institution.
Loss of AXIN1 drives acquired resistance to WNT pathway blockade in colorectal cancer cells carrying RSPO3 fusions.
- Published in:
- EMBO Molecular Medicine, 2017, v. 9, n. 3, p. 293, doi. 10.15252/emmm.201606773
- By:
- Publication type:
- Article
Editorial: The impact of genetics on CRC therapy: from adaptive mutability to drug resistance.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1260158
- By:
- Publication type:
- Article
Erratum: Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients.
- Published in:
- Nature Medicine, 2015, v. 21, n. 7, p. 827, doi. 10.1038/nm0715-827b
- By:
- Publication type:
- Article
Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients.
- Published in:
- Nature Medicine, 2015, v. 21, n. 7, p. 795, doi. 10.1038/nm.3870
- By:
- Publication type:
- Article
Sequence Analysis of 96 Genomic Regions Identifies Distinct Evolutionary Lineages within CC156, the Largest <i>Streptococcus pneumoniae</i> Clonal Complex in the MLST Database.
- Published in:
- PLoS ONE, 2013, v. 8, n. 4, p. 1, doi. 10.1371/journal.pone.0061003
- By:
- Publication type:
- Article
Mutational Signatures in Colorectal Cancer: Translational Insights, Clinical Applications, and Limitations.
- Published in:
- Cancers, 2024, v. 16, n. 17, p. 2956, doi. 10.3390/cancers16172956
- By:
- Publication type:
- Article
PARP1 Inhibitor and Trabectedin Combination Does Not Increase Tumor Mutational Burden in Advanced Sarcomas—A Preclinical and Translational Study.
- Published in:
- Cancers, 2021, v. 13, n. 24, p. 6295, doi. 10.3390/cancers13246295
- By:
- Publication type:
- Article
Transcriptome‐wide gene expression outlier analysis pinpoints therapeutic vulnerabilities in colorectal cancer.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 6, p. 1460, doi. 10.1002/1878-0261.13622
- By:
- Publication type:
- Article
Genetic Evolution of Glioblastoma Stem-Like Cells From Primary to Recurrent Tumor.
- Published in:
- Stem Cells, 2017, v. 35, n. 11, p. 2218, doi. 10.1002/stem.2703
- By:
- Publication type:
- Article
Mutational signatures of colorectal cancers according to distinct computational workflows.
- Published in:
- Briefings in Bioinformatics, 2024, v. 25, n. 4, p. 1, doi. 10.1093/bib/bbae249
- By:
- Publication type:
- Article
Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer.
- Published in:
- Nature Communications, 2016, v. 7, n. 12, p. 13665, doi. 10.1038/ncomms13665
- By:
- Publication type:
- Article
Emergence of MET hyper-amplification at progression to MET and BRAF inhibition in colorectal cancer.
- Published in:
- British Journal of Cancer, 2017, v. 117, n. 3, p. 347, doi. 10.1038/bjc.2017.196
- By:
- Publication type:
- Article
Emergence of MET hyper-amplification at progression to MET and BRAF inhibition in colorectal cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A Genomic Analysis Workflow for Colorectal Cancer Precision Oncology.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Liquid biopsies to monitor and direct cancer treatment in colorectal cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Case report: Preclinical efficacy of NEDD8 and proteasome inhibitors in patient-derived models of signet ring high-grade mucinous colorectal cancer from a Lynch syndrome patient.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1130852
- By:
- Publication type:
- Article
DNA damage response and repair genes in advanced bone and soft tissue sarcomas: An 8- gene signature as a candidate predictive biomarker of response to trabectedin and olaparib combination.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.844250
- By:
- Publication type:
- Article